Australia markets closed

MedX Health Corp (MDX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.06500.0000 (0.00%)
At close: 01:30PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 17.03M
Enterprise value 22.67M
Trailing P/E N/A
Forward P/E 23.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)21.78
Price/book (mrq)N/A
Enterprise value/revenue 37.63
Enterprise value/EBITDA -7.00

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 316.67%
S&P500 52-week change 328.64%
52-week high 30.0900
52-week low 30.0300
50-day moving average 30.0530
200-day moving average 30.0630

Share statistics

Avg vol (3-month) 3118.37k
Avg vol (10-day) 3141.55k
Shares outstanding 5261.96M
Implied shares outstanding 6285.77M
Float 8182.61M
% held by insiders 16.41%
% held by institutions 10.01%
Shares short (29 Feb 2024) 4376
Short ratio (29 Feb 2024) 40.43
Short % of float (29 Feb 2024) 4N/A
Short % of shares outstanding (29 Feb 2024) 40.03%
Shares short (prior month 31 Jan 2024) 43k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-750.06%

Management effectiveness

Return on assets (ttm)-277.82%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)602.57k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)23.40%
Gross profit (ttm)N/A
EBITDA -3.41M
Net income avi to common (ttm)-5.36M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)186.15k
Total cash per share (mrq)0
Total debt (mrq)5.83M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.09
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-3.77M
Levered free cash flow (ttm)-3.18M